评估一项多组分、社区为基础的干预项目对津巴布韦HIV感染青少年治疗依从性和留存率的影响:整群随机对照试验研究方案
该整群随机对照试验在津巴布韦两个地区16家诊所开展,评估社区为基础的心理社会干预对HIV感染青少年(13-19岁)病毒学失败和留存率的影响。干预组接受每月支持小组、社区青少年治疗支持者、短信和电话及家访等额外支持,对照组接受标准护理。主要结局为96周时死亡或病毒学失败(病毒载量≥1000拷贝/ml)的比例。
要点
- WHO指南推荐社区干预支持青少年HIV感染者ART依从和留存,但证据薄弱。
- 试验在津巴布韦两个地区16家诊所整群随机,比较增强支持与标准护理。
- 主要结局为96周时死亡或病毒学失败(病毒载量≥1000拷贝/ml)的比例。
核心结论
- 该研究为正在实施的Zvandiri项目在真实世界中影响HIV感染青少年病毒学失败和心理社会结局提供独特证据机会。
- 若发现可降低治疗失败率,将加强对津巴布韦及更广泛地区进一步扩大规模的支持。
研究设计与样本
- 整群随机对照试验,在津巴布韦两个地区16家诊所开展,随机分配至增强ART依从支持或标准护理。
- 符合条件的个体为13-19岁HIV阳性且符合ART条件的青少年,两组均接受成人咨询师和护理人员提供的ART及依从支持。
- 干预组额外参加每月支持小组、分配指定社区青少年治疗支持者、通过短信和电话及家访随访,接触类型和频率根据青少年是否「稳定」或需增强支持而定。
- 稳定青少年接受每月家访加每周个体化短信,若错过预约门诊或支持小组会议则额外家访;需进一步增强支持者接受每两周家访、每周电话和每日短信。
- 干预组青少年的照护者参加照护者支持小组。
主要发现
- 主要结局为96周时死亡或病毒学失败(病毒载量≥1000拷贝/ml)的比例。
- 次要结局包括48周时病毒学失败、留存率(错过就诊的比例)和两个时间点的心理社会结局。
关键数值与推荐
- 主要结局阈值:病毒学失败定义为病毒载量≥1000拷贝/ml。
- 统计分析将按照整群随机试验的CONSORT指南进行和报告,包括流程图。
临床怎么用
- 原文未据此给出推荐。
局限性
- WHO指南承认支持社区干预推荐的证据薄弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: World Health Organization (WHO) adolescent HIV-testing and treatment guidelines recommend community-based interventions to support antiretroviral therapy (ART) adherence and retention in care, while acknowledging that the evidence to support this recommendation is weak. This cluster randomized controlled trial aims to evaluate the effectiveness and cost-effectiveness of a psychosocial, community-based intervention on HIV-related and psychosocial outcomes. METHODS/DESIGN: We are conducting the trial in two districts. Sixteen clinics were randomized to either enhanced ART-adherence support or standard of care. Eligible individuals (HIV-positive adolescents aged 13-19 years and eligible for ART) in both arms receive ART and adherence support provided by adult counselors and nursing staff. Adolescents in the intervention arm additionally attend a monthly support group, are allocated to a designated community adolescent treatment supporter, and followed up through a short message service (SMS) and calls plus home visits. The type and frequency of contact is determined by whether the adolescent is "stable" or in need of enhanced support. Stable adolescents receive a monthly home visit plus a weekly, individualized SMS. An additional home visit is conducted if participants miss a scheduled clinic appointment or support-group meeting. Participants in need of further, enhanced, support receive bi-weekly home visits, weekly phone calls and daily SMS. Caregivers of adolescents in the intervention arm attend a caregiver support group. Trial outcomes are assessed through a clinical, behavioral and psychological assessment conducted at baseline and after 48 and 96 weeks. The primary outcome is the proportion who have died or have virological failure (viral load ≥1000 copies/ml) at 96 weeks. Secondary outcomes include virological failure at 48 weeks, retention in care (proportion of missed visits) and psychosocial outcomes at both time points. Statistical analyses will be conducted and reported in line with CONSORT guidelines for cluster randomized trials, including a flowchart. DISCUSSION: This study provides a unique opportunity to generate evidence of the impact of the on-going Zvandiri program, for adolescents living with HIV, on virological failure and psychosocial outcomes as delivered in a real-world setting. If found to reduce rates of treatment failure, this would strengthen support for further scale-up across Zimbabwe and likely the region more widely. TRIAL REGISTRATION: Pan African Clinical Trial Registry database, registration number PACTR201609001767322 (the Zvandiri trial). Retrospectively registered on 5 September 2016.
引用
- Mavhu W, Willis N, Mufuka J, et al. Evaluating a multi-component, community-based program to improve adherence and retention in care among adolescents living with HIV in Zimbabwe: study protocol for a cluster randomized controlled trial. Trials. 2017. PMID: 29052529. doi:10.1186/s13063-017-2198-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。